Orbit Discovery is a peptide display technology company that identifies peptide drugs for chronic diseases. The Company’s Orbit in vitro display technology uses small beads to link randomized peptide sequences to the DNA which encodes them; and provides screening tools that support the discovery of peptides for a range of disease types. It focuses on establishing a screening platform that identifies peptide drug candidates for internal industry drug discovery programs and via collaborative research.
|Employees (est.) (Sept 2020)||32|
Orbit Discovery total Funding
Orbit Discovery latest funding size
Time since last funding
|2 years ago|
Orbit Discovery investors
|Borealis Ventures, Oxford Technology Management, Oxford Sciences Innovation, Perivoli Innovations, RT Ventures, Oxford University|
|GBP||FY, 2017||FY, 2018|
When was Orbit Discovery founded?
Orbit Discovery was founded in 2015.
Who are Orbit Discovery key executives?
Orbit Discovery's key executives are Alex Batchelor, Terry Rabbitts and Graham Ogg.
How many employees does Orbit Discovery have?
Orbit Discovery has 32 employees.
Who are Orbit Discovery competitors?
Competitors of Orbit Discovery include TauRx, Symcel and SAVA Healthcare.
Where is Orbit Discovery headquarters?
Orbit Discovery headquarters is located at Magdalen Centre, Robert Robinson Ave, Littlemore, Oxford.
Where are Orbit Discovery offices?
Orbit Discovery has offices in Oxford and London.
How many offices does Orbit Discovery have?
Orbit Discovery has 2 offices.
Receive alerts for 300+ data fields across thousands of companies